Stockscreener 앱 받기
4.49
0.00%
0.00
전일 마감가:
$4.49
열려 있는:
$4.49
하루 거래량:
35,034
Relative Volume:
0.39
시가총액:
$116.43M
수익:
$40,000
순이익/손실:
$-38.64M
주가수익비율:
-2.4384
EPS:
-1.8414
순현금흐름:
$-22.21M
1주 성능:
+1.58%
1개월 성능:
-1.32%
6개월 성능:
-55.10%
1년 성능:
-7.99%
1일 변동 폭
$4.37
$4.515
1주일 범위
$4.26
$4.5399
52주 변동 폭
$3.69
$12.99
Neonc Technologies Holdings Inc Stock (NTHI) Company Profile
명칭
Neonc Technologies Holdings Inc
전화
310 663 7831
주소
23975 PARK SORRENTO, CALABASAS
Compare NTHI vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NTHI
Neonc Technologies Holdings Inc
|
4.49 | 116.43M | 40,000 | -38.64M | -22.21M | -1.8414 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Neonc Technologies Holdings Inc 주식(NTHI)의 최신 뉴스
NeOnc Technologies Holdings, Inc. (NTHI) 8-K Filing: Director and Officer Changes Announced – Nasdaq Emerging Growth Company Update – Minichart - Minichart
NeOnc Technologies Adds New Director Amid Governance Focus - TipRanks
New NeOnc (NASDAQ: NTHI) director is CEO's niece - Stock Titan
NeOnc Technologies Holdings, Inc. Financial Disclosures & SEC Filings - TradingView
NeOnc Technologies Holdings (NTHI) Investor Relations, Earnings Summary & Outlook - Quartr
NeOnc Technologies Holdings, Inc. (NTHI) Stock Price, News, Quote & History - Yahoo! Finance Canada
NeOnc Technologies Holdings, Inc.(NasdaqGM:NTHI) dropped from Russell 3000E Growth Benchmark - marketscreener.com
NeOnc Technologies Holdings, Inc.(NasdaqGM:NTHI) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
NTHI Q1 2026 Earnings: EPS Misses Estimates as Company Focuses on Pipeline DevelopmentEarnings Expansion Phase - dars.gov.et
NTHI Forecast — Price Target — Prediction for 2027 - TradingView
NeOnc Technologies Holdings, Inc. Actuals & Estimates (NASDAQ:NTHI) - TradingView
NeOnc Technologies Holdings, Inc. Actuals & Estimates (BOATS:NTHI) - TradingView
NeOnc Technologies Holdings, Inc. announced that it has received $5.00004 million in funding - marketscreener.com
NeOnc Ignites Explosive Summer: 4 New Research Reports + UAE/Dubai Drug Approval Fuel Breakout Momentum - The Manila Times
NeOnc Technologies Holdings Secures Second UAE IND Authorization for NEO100, Expanding Global CNS Cancer Development Program - Moomoo
[EFFECT] NEONC TECHNOLOGIES HOLDINGS, INC. SEC Filing - Stock Titan
NeOnc Technologies Receives UAE IND Approval for NEO100, Expanding Global Development Ahead of Anticipated Phase 2 Data Milestone - Sahm
Form 424B5 Neonc Technologies Holdings Inc For: 23 June By Investing.com - Investing.com India
NeOnc wins another UAE clearance as brain-cancer data nears - Stock Titan
Form DEF 14A NEONC TECHNOLOGIES HOLDINGS For: 23 June By Investing.com - Investing.com South Africa
NeOnc Wins Abu Dhabi IND Clearance for NEO100 - TipRanks
NeOnc Technologies (NASDAQ: NTHI) details 2026 virtual meeting, board elections and plan changes - Stock Titan
NeOnc Technologies Receives UAE IND for NEO100, Phase 2a Readout Expected by End of July - TradingView
NeOnc Technologies (Nasdaq: NTHI) wins UAE IND for NEO100 ahead Phase 2a data - Stock Titan
NeOnc (NTHI) registers 555,554 shares for resale, includes 277,777‑share warrant - Stock Titan
NeOnc receives UAE approval for NEO100 glioma drug trials By Investing.com - Investing.com South Africa
NeOnc receives UAE approval for NEO100 glioma drug trials - Investing.com
NeOnc Technologies Receives UAE IND Approval for NEO100, - GlobeNewswire
NeOnc Secures Abu Dhabi IND Authorization for NEO212 - Intellectia AI
WSTPR Catalyst Watch: Abu Dhabi Regulatory Clearance Adds Momentum to NeOnc's Global Neuro-Oncology Strategy - TMX Newsfile
NTHI Q1 2026 Earnings: Wider-than-Expected Loss as EPS Misses EstimatesEarnings Growth Analysis - dars.gov.et
NeOnc Technologies Secures UAE IND Approval for NEO212, Advancing Global Phase 2 Trials for Aggressive Brain Tumors - Minichart
NeOnc Wins UAE IND Clearance for NEO212 Brain Therapy - TipRanks
NeOnc secures Abu Dhabi IND for NEO212, clears path to Phase 2 at 610 mg - TradingView
NTHI - Finviz
NeOnc Technologies Holdings Inc (NTHI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
NeOnc Technologies Holdings Inc - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Institutional Confidence - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Valuation: PE, PB & Fair Value Analysis - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
NeOnc Technologies Holdings Inc (NTHI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
NeOnc's Global Expansion Accelerates After Abu Dhabi IND Approval for NEO212 - The Manila Times
Brain Cancer Innovator NeOnc Heads into Critical Data Season with Fresh Abu Dhabi IND - The Manila Times
NeOnc's Global Gambit: Abu Dhabi Nod Accelerates Brain Cancer Attack - BriefGlance
Top Biotech Gainers: CRVO On Watch, SLP Scooped Up, LNAI Back In Compliance, NTHI Advances NEO212 - RTTNews
NeOnc Technologies Holdings Secures IND Authorization for NEO212, Advancing Clinical Programs for Aggressive Brain Cancers - Quiver Quantitative
Neonc Technologies Secures UAE IND Approval For NEO212 Following Successful Phase 1 Completion, Advancing Toward Global Phase 2 Development - Mena FN
NeOnc Technologies Secures UAE IND Approval for NEO212 Following Successful Phase 1 Completion, Advancing Toward Global Phase 2 Development - Asianet Newsable
Neonc Technologies Holdings Inc (NTHI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Neonc Technologies Holdings Inc 주식 (NTHI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Heshmatpour Amir F | President |
Apr 28 '26 |
Buy |
4.52 |
10,000 |
45,180 |
3,062,000 |
| Neman-Ebrahim Yousha | Chief Clinical Officer |
Apr 23 '26 |
Buy |
4.88 |
500 |
2,440 |
134,760 |
| Heshmatpour Amir F | President |
Apr 23 '26 |
Buy |
4.90 |
10,000 |
49,000 |
3,052,000 |
| SUH, DAVID JR. | Chief Accounting Officer |
Apr 09 '26 |
Buy |
5.00 |
200 |
1,000 |
111,866 |
| Heshmatpour Amir F | President |
Apr 10 '26 |
Buy |
4.89 |
10,000 |
48,950 |
3,042,000 |
| Heshmatpour Amir F | President |
Apr 08 '26 |
Buy |
5.61 |
10,000 |
56,050 |
3,027,000 |
| Heshmatpour Amir F | President |
Apr 09 '26 |
Buy |
5.19 |
5,000 |
25,950 |
3,032,000 |
| Heshmatpour Amir F | President |
Apr 02 '26 |
Buy |
6.09 |
20,000 |
121,798 |
3,012,000 |
| Heshmatpour Amir F | President |
Apr 06 '26 |
Buy |
6.32 |
5,000 |
31,600 |
3,017,000 |
| Heshmatpour Amir F | President |
Nov 21 '25 |
Buy |
6.07 |
24,000 |
145,600 |
2,986,000 |
2.64%
자본화:
|
볼륨(24시간):